+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Wound Biologics Market Research Report by Product, Wound Type, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 259 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989966
UP TO OFF until Dec 31st 2022
The Global Wound Biologics Market size was estimated at USD 4,241.55 million in 2021, USD 4,585.62 million in 2022, and is projected to grow at a CAGR of 9.15% to reach USD 7,175.51 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Wound Biologics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products.
  • Based on Wound Type, the market was studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers.
  • Based on End-User, the market was studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Wound Biologics market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Wound Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Wound Biologics Market, including 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., Bioventus Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MIMEDX GROUP, INC., Mölnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Tides Medical, Vericel Corporation, and Viatris Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Wound Biologics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Wound Biologics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wound Biologics Market?
4. What is the competitive strategic window for opportunities in the Global Wound Biologics Market?
5. What are the technology trends and regulatory frameworks in the Global Wound Biologics Market?
6. What is the market share of the leading vendors in the Global Wound Biologics Market?
7. What modes and strategic moves are considered suitable for entering the Global Wound Biologics Market?
Frequently Asked Questions about the Global Wound Biologics Market

What is the estimated value of the Global Wound Biologics Market?

The Global Wound Biologics Market was estimated to be valued at $4241.55 Million in 2021.

What is the growth rate of the Global Wound Biologics Market?

The growth rate of the Global Wound Biologics Market is 9.1%, with an estimated value of $7175.51 Million by 2027.

What is the forecasted size of the Global Wound Biologics Market?

The Global Wound Biologics Market is estimated to be worth $7175.51 Million by 2027.

Who are the key companies in the Global Wound Biologics Market?

Key companies in the Global Wound Biologics Market include 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., Bioventus Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Integra Lifesciences Holdings Corporation, Kerecis hf and MIMEDX GROUP, INC..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Government Initiatives Regarding Wound Care Treatment
5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
5.1.1.3. Increasing Geriatric Population Globally
5.1.2. Restraints
5.1.2.1. High Cost of Wound Treatment
5.1.3. Opportunities
5.1.3.1. Introduction of Innovative Wound Care Biologics
5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
5.1.4. Challenges
5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
5.2. Cumulative Impact of COVID-19
6. Wound Biologics Market, by Product
6.1. Introduction
6.2. Biologic Skin Substitutes
6.3.1. Acellular Animal-derived Products
6.3.2. Biosynthetic Products
6.3.3. Human Donor Tissue-derived Products
6.3. Topical Agents
7. Wound Biologics Market, by Wound Type
7.1. Introduction
7.2. Burns
7.3. Surgical and Traumatic Wounds
7.4. Ulcers
7.5.1. Diabetic Foot Ulcers
7.5.2. Pressure Ulcers
7.5.3. Venous Ulcers
8. Wound Biologics Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Burn Centers
8.4. Hospitals
8.5. Wound Clinics
9. Americas Wound Biologics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Wound Biologics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Wound Biologics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Anika Therapeutics, Inc
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Avita Medical, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Bioventus Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. ConvaTec Group PLC
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Cytori Therapeutics Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Integra Lifesciences Holdings Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Kerecis hf
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Marine Polymer Technologies, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. MIMEDX GROUP, INC.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Mölnlycke Health Care AB
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Nuo Therapeutics, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Organogenesis Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Skye Biologics Holdings, LLC
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Smith & Nephew PLC
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Stability Biologics
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Stryker Corporation
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Tides Medical
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Vericel Corporation
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Viatris Inc.
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL WOUND BIOLOGICS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET DYNAMICS
FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2027
FIGURE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, 2018-2027 (USD MILLION)
FIGURE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2021 VS 2027 (%)
FIGURE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY WOUND TYPE, 2027
FIGURE 22. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, 2018-2027 (USD MILLION)
FIGURE 24. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, 2018-2027 (USD MILLION)
FIGURE 26. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 29. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2027
FIGURE 31. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
FIGURE 32. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, 2018-2027 (USD MILLION)
FIGURE 35. AMERICAS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 37. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 38. AMERICAS WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 39. ARGENTINA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 40. BRAZIL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 41. CANADA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 42. MEXICO WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 43. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 44. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. UNITED STATES WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 47. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 49. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 51. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 52. CHINA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 53. INDIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 54. INDONESIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. JAPAN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. MALAYSIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. SINGAPORE WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 60. TAIWAN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 61. THAILAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. VIETNAM WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 67. DENMARK WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. EGYPT WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. FINLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. FRANCE WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. GERMANY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. ISRAEL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. ITALY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. NIGERIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. NORWAY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. POLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. QATAR WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. RUSSIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. SPAIN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. SWEDEN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. TURKEY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. GLOBAL WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 89. GLOBAL WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 90. GLOBAL WOUND BIOLOGICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 54. AMERICAS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 56. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 57. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 58. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 59. ARGENTINA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 60. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 61. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 62. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 63. BRAZIL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 64. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 65. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 66. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 67. CANADA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 68. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 69. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 70. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 71. MEXICO WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 72. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 73. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 74. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 75. UNITED STATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 76. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 77. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 78. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 79. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 85. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 86. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 87. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 88. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 89. CHINA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 90. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 91. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 92. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 93. INDIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 94. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 95. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 96. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 97. INDONESIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 98. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 99. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 100. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 101. JAPAN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 102. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 103. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 104. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 105. MALAYSIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 106. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 107. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 108. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 109. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 110. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 111. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 112. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 113. SINGAPORE WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 114. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 115. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 116. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 117. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 119. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 120. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 121. TAIWAN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 122. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 123. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 124. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 125. THAILAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 126. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 127. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 128. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 129. VIETNAM WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 131. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 132. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 138. DENMARK WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 140. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 141. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 142. EGYPT WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 143. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 144. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 145. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 146. FINLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 147. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 148. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 149. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 150. FRANCE WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 151. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 152. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 153. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 154. GERMANY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 155. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 156. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 157. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 158. ISRAEL WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 159. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 160. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 161. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 163. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 164. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 165. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 168. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 169. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 170. NIGERIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 173. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 174. NORWAY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 175. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 178. POLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 179. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 180. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 182. QATAR WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 183. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 184. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 185. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 186. RUSSIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 187. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 188. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 189. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 190. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 191. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 192. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 193. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 194. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 195. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 196. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 197. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 198. SPAIN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 199. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 200. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 201. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 202. SWEDEN WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 203. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 204. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 205. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 206. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 207. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 208. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 209. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 210. TURKEY WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 211. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 212. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 213. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 218. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 219. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 220. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2027 (USD MILLION)
TABLE 221. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2027 (USD MILLION)
TABLE 222. GLOBAL WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 223. GLOBAL WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 224. GLOBAL WOUND BIOLOGICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 225. GLOBAL WOUND BIOLOGICS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 226. GLOBAL WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 227. GLOBAL WOUND BIOLOGICS MARKET MERGER & ACQUISITION
TABLE 228. GLOBAL WOUND BIOLOGICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 229. GLOBAL WOUND BIOLOGICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 230. GLOBAL WOUND BIOLOGICS MARKET INVESTMENT & FUNDING
TABLE 231. GLOBAL WOUND BIOLOGICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 232. GLOBAL WOUND BIOLOGICS MARKET: LICENSE & PRICING

Companies Mentioned

  • 3M Company
  • Anika Therapeutics, Inc
  • Avita Medical, Inc.
  • Bioventus Inc.
  • ConvaTec Group PLC
  • Cytori Therapeutics Inc.
  • Integra Lifesciences Holdings Corporation
  • Kerecis hf
  • Marine Polymer Technologies, Inc.
  • MIMEDX GROUP, INC.
  • Mölnlycke Health Care AB
  • Nuo Therapeutics, Inc.
  • Organogenesis Inc.
  • Skye Biologics Holdings, LLC
  • Smith & Nephew PLC
  • Stability Biologics
  • Stryker Corporation
  • Tides Medical
  • Vericel Corporation
  • Viatris Inc.

Methodology

Loading
LOADING...